During the past decade, Les Urologues Associes du CHUM conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Les Urologues Associes du CHUM" are "Benign Prostatic Hyperplasia" (1 trials) and "Metastatic Renal Cell Cancer" (1 trials). Many other conditions were trialed in "Les Urologues Associes du CHUM" in a lesser frequency.

Most popular intervention types in "Les Urologues Associes du CHUM" are "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Combination of 2007RD01 and saw palmetto lipidic extract" (1 trials), "Everolimus" (1 trials) and "Saw palmetto lipidic extract" (1 trials). Other intervention names were less common.

The vast majority of trials in "Les Urologues Associes du CHUM" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Les Urologues Associes du CHUM". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Les Urologues Associes du CHUM, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Les Urologues Associes du CHUM, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".